This lab-designed antibody treatment can treat COVID-19 and block infection, though its cost means it may be reserved for the most vulnerable.
A merger between two digital mental health companies – Headspace and Ginger – will create a $3 billion The post Digital mental health firms Headspace and...
Everyone is familiar with the phrase ‘patient-centricity’ but, where it might once have been seen as a ‘checkbox The post Amplifying the patient voice for better...
Scientists Race To Unlock Mysteries Of "COVID Resistance" Seen In Small Number Of People Like with virtually every other virus (including HIV), it appears a tiny...
Artificial intelligence is emerging from its overhyped past to provide analytical muscle in precision medicine. The post From Hype to Utility appeared first on Clinical OMICs...
FDA, some experts at odds over agency’s accelerated approval for Aduhelm, the Alzheimer’s disease drug from Biogen and Eisai. The post Green Light Raises Red Flags...
Meditation app Headspace this morning announced plans to merge with on-demand mental health service, Ginger. Barring unforeseen regulatory roadblocks, the two companies will combine to form...
With health care giants like Pfizer firing on all cylinders, these health care stocks could be in the spotlight now. The post Top Health Care Stocks...
What does the FDA approval of Pfizer-BioNTech's coronavirus vaccine mean for the stock market today. The post Pfizer-BioNTech Vaccine FDA Approval, 7 Things To Know &...
Are these top penny stocks on your small-caps watchlist The post Top Penny Stocks You Need to Know About Right Now appeared first on Penny Stocks...
The UK drug regulator approved an antibody cocktail developed by Regeneron and Roche to prevent and treat Covid-19, as the nation battles rising hospitalizations due to...
Jim Kelly → The perennial Charlie Brown of vaccine development, Novavax is grappling with Lucy’s knack for pulling the football away once again, this time with...
A large, randomized, placebo-controlled trial found that the administration of Covid-19 convalescent plasma to high-risk outpatients did not prevent the progression of Covid-19, according to results...
Small Caps to buy according to analysts with price targets up to 300% right now...
Are these trending penny stocks worth buying? 3 to watch The post Best Penny Stocks to Buy Now? 3 That Traders Are Watching in August appeared...
Biotechs inhabit their own universe within the stock market. Prone to huge upward or downward swings dependent on positive or negative news flow. They are also...
After the historic approval of the company's first-ever drug in January 2021, Aurinia Pharmaceuticals announced the acquisition of two pipeline assets that align with the Canadian biotech's focus...
Bioregnum Opinion Column by John Carroll Adam Koppel filed his first Form D for his life sciences group at Bain almost exactly 5 years ago. After...
Reddit penny stocks are heating up, here's 3 to watch right now The post Reddit Penny Stocks to Buy? 3 That You Probably Don’t Know About...
Health Canada has started a rolling review of Merck & Co’s molnupiravir, an oral antiviral therapy treatment for The post Merck kicks off oral COVID-19 antiviral...
Prior to its $3.2 billion acquisition of mRNA player Translate Bio earlier this month, French drugmaker Sanofi considered dumping a quarter of its shares in the...
Researchers are piecing together clues to better understand the puzzling array of symptoms in those who never seem to fully recover from COVID-19.
Spatial biology is among the smaller segments of the broader life sciences market. In GEN’s first-ever top-10 A-List for spatial biology biology there are five of...
With the health care industry coming into focus again, these biotech stocks could be worth considering. The post Best Biotech Stocks To Watch In 2021? 4...
Best trending penny stocks to watch now? Check these 3 out for your watchlist The post Trending Penny Stocks to Buy Now? 3 Small-Caps to Watch...
TORONTO – In another step towards increasing digital access to mental health care, the Green Shield Canada group of companies is pleased to announce its...
When pharmaceutical Pfizer recently giant disclosed it was earmarking up to US$1 billion for its oral antiviral drug candidate (PF-07321332)—before knowing the Phase 2/3 blinded trial...
Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021 Partnership being developed...
90% Of Patients Treated With Experimental Israeli COVID Drug Discharged Within 5 Days Finally, it looks like the world might be on the verge of obtaining...
Would these vaccine stocks make for good investments amidst the current wave of coronavirus infections? The post Best Stocks To Buy Now? 4 Vaccine Stocks To...